Purpose: To determine the incidence, clinical features, and outcomes of infectious endophthalmitis after Boston Type 1 Keratoprosthesis (KPro) implantation.
T he Boston Type 1 keratoprosthesis (KPro) has been used in the management of eyes with multiple failed penetrating keratoplasties (PKs), chemical injuries, bullous keratopathy, Stevens-Johnson syndrome (SJS), ocular cicatricial pemphigoid, herpes simplex virus keratitis, aniridic fibrosis syndrome, and other ocular diseases. 1 Infectious endophthalmitis is a devastating complication associated with poor visual outcomes. 2, 3 There are just a few reports in the literature that examine the characteristics of patients who develop this complication after KPro implantation. [4] [5] [6] [7] The addition of vancomycin and a quinolone to the bacterial prophylaxis regimen after KPro implantation has reduced the occurrence of bacterial endophthalmitis. 7, 8 However, the risk of fungal colonization and infection in KPro has since appeared. 5 We present the characteristics, management, and outcomes of 3 patients who developed endophthalmitis after KPro implantation at the Cincinnati Eye Institute.
METHODS
A retrospective chart review of 105 patients (126 eyes) who had undergone KPro implantation at the Cincinnati Eye Institute between November 2004 and November 2010 and were followed up for at least 1 month postoperatively (range, 1 month to 5.92 years; mean, 3.42 years) was conducted. Three cases were identified to have developed endophthalmitis after KPro implantation. Information on the incidence, presenting features, causative organisms, management, and patient demographical and visual acuity outcomes was recorded.
RESULTS
The incidence of endophthalmitis was 2.4% (3 of 126 eyes) and occurred at 4, 11, and 35 months after surgery. There were 3 cases of endophthalmitis over 2582 accumulated patient-months of follow-up, or 0.014 infections per patientyear. Patient characteristics are summarized in Table 1 . Mean patient age was 52 years. All 3 patients were women. Two patients had KPro implantation because of PK failure and 1 patient had necrosis of a previous KPro cornea. One patient had a history of congenital glaucoma. Two patients had a diagnosis of SJS, 1 of whom had previous living-related conjunctival limbal allograft combined with keratolimbal allograft (''Cincinnati Procedure'') limbal stem cell transplant surgery. 9 All patients since the time of K-pro implantation wore a bandage contact lens (Kontur Kontact Lens Co, Inc, Hercules, CA) that was changed every 3 months. Antibiotic prophylaxis consisted of 250 mg of cephalexin 4 times daily for 1 week after surgery, with 14 mg/mL of vancomycin and a fourth-generation fluoroquinolone (moxifloxacin) 4 times daily immediately after surgery for 1 month and then tapered to twice daily. All patients were also on a topical steroid for management of chronic inflammation 4 times daily immediately after surgery for 1 month and then tapered to twice daily. One patient with SJS was taking systemic immunosuppression medications at the time of endophthalmitis development.
Features of the endophthalmitis are summarized in Table 2 . All patients presented with decreased vision. Only 1 patient complained of pain [probably because of the hypotony associated with her chronic retinal detachment (RD)]. The other patient who presented with an RD complained of new onset floaters and on examination had a dense retroprosthetic membrane that was not noted 2 months before.
All patients were referred to the retina service. Causative pathogens were found in vitreous fluid cultures for all patients:
Ochrobactrum anthropi, Candida parapsilosis, and Candida albicans. One patient (case 1) had a contact lens that was culture-positive for Staphylococcus aureus but sensitive to vancomycin. Initial broad-spectrum antibiotics and antifungals were used based on clinical findings (Table 2) Visual outcomes were poor for the 2 patients who presented with vision decreased to light perception (LP). Those 2 patients did not recover any further vision beyond LP. One patient, who presented with decreased vision of 20/400 recovered a visual acuity of 20/60.
DISCUSSION
The incidence of endophthalmitis in our study, 2.4% (3 of 126 KProeyes) more than 2582months ofaccumulated follow-up for all 126 KPro eyes or 1.4% per patient-year, is lower than the incidence reported in other series: 11.4% 6 and 12%
4
-where vancomycin was not routinely used but more than 1 large series where gram-positive cocci were reported to have caused more than 80% of the cases (0.35% per patient-year). 7 Two of the 3 cases in our series occurred because of fungal organisms for an overall rate of 0.009 infections per patient-year of follow-up, which is identical to that reported by Barnes et al. 5 Two patients (cases 2 and 3) in this series had a diagnosis of SJS. In a study published before the widespread use of vancomycin, eyes with autoimmune conjunctivitis were found to have a higher incidence of gram-positive bacterial endophthalmitis. 4 It is difficult to determine statistically significant predictors for fungal endophthalmitis in small case series, such as this study. Further investigation is certainly warranted to determine the risk factors for endophthalmitis with current anti-infective prophylaxis regimens. Another article reports just 1 case of sterile vitritis and no cases of endophthalmitis after KPro implantation in 16 eyes with SJS. 10 One patient in our series (case 3) had known issues with noncompliance that has been associated with more infections. 6 Case 1 likely had noncompliance issues as well because cultures from both the contact lens and the vitreous were positive for organisms sensitive to drugs that the patient was supposed to take.
The pathogens cultured from the vitreous in this series included a gram-negative bacillus, O. anthropi, and 2 Candida species (C. parapsilosis and C. albicans). Nouri et al 4 reported no gram-negative isolates, but Fintelmann et al 6 had 1 case of Pseudomonas. In the study of Barnes et al 5 on fungal colonization, C. parapsilosis predominated when both infections and surveillance colonization were considered. Both O. anthropi and C. parapsilosis have been reported to be related to indwelling catheters for venous access or other permanent plastic medical devices. 11, 12 Ochrobactrum anthropi is also known to have caused endophthalmitis after intraocular surgery. [13] [14] [15] [16] [17] One patient (case 2) was on systemic immunosuppression medications of mycophenolate mofetil, tacrolimus, and prednisone, at the time of her fungal endophthalmitis. In the report of Nouri et al 4 , 1 patient developed S. epidermidis endophthalmitis while on systemic azathioprine and cyclosporine.
Infectious endophthalmitis is a devastating complication usually associated with poor visual outcomes.
2,3 Presenting complaints are usually decreased vision, pain, red eye, and hypopyon. 3 In our series, all patients complained of decreased vision, 1 had AC hypopyon, and 1 complained of increased floaters with an acute dense retroprosthetic membrane noted on examination. Only 1 patient presented with pain, which was likely because of hypotony from a chronic RD. These presenting findings are similar to those reported by Fintelmann et al, 6 whose patients complained of painless visual decline. Presenting features of infectious endophthalmitis after KPro implantation in patients on vancomycin and fluoroquinolone prophylaxis from other reports are summarized in Table 3 . 
